Skip to main content

Incannex Healthcare Limited (IXHL)

Incannex Healthcare will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap452.36M
Revenue (ttm)1.37M
Net Income (ttm)-4.14M
Shares Out45.24M
EPS (ttm)-0.09
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About IXHL

Since 2019, Incannex Healthcare has been conducting research and development for synthetic cannabidiol pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. Our mission is to create first-in-class pharmaceutical drugs and therapies for patients that we believe have unmet medical needs. In particular, we are developing three unique pharmaceutical compositions to target five indications: obstructive sleep apnea, traumatic brain injury/concussion, rheumatoid arthritis, inflammatory bowel disease and in...

IndustryPharmaceutical Preparations
Founded2001
CEOJoel Latham
Employees4
Stock ExchangeNASDAQ
Ticker SymbolIXHL
Full Company Profile

Financial Performance

Financial numbers in millions AUDFinancial Statements

News

Incannex Healthcare (ASX:IHL) files registration statement for proposed IPO in US

Incannex Healthcare (ASX:IHL) has filed a registration statement with the United States' Securities and Exchange Commission in relation to a proposed US public offering (IPO).

3 months ago - The Market Herald

Incannex Healthcare IPO Registration Document (S-1)

Incannex Healthcare Limited has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC